Home/ Stocks/ TERN

Terns Pharmaceuticals, Inc. Common Stock

TERN XNAS

$50.00 +0.31 (+0.63%) ▲ 15-min delayed

Open

$49.22

High

$50.37

Low

$48.14

Volume

2.54M

Market Cap

$5.40B

About Terns Pharmaceuticals, Inc. Common Stock

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 59 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-24,635,000	$-0.27
Q2 2025	$0	$-24,093,000	$-0.26
Q1 2025	$0	$-23,908,000	$-0.26
FY 2024	$0	$-88,853,000	$-1.12

Related Market News

No specific coverage for TERN yet. Check out our latest market news or earnings calendar.

Get TERN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Terns Pharmaceuticals, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.